πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,413 results for β€œChinese” Clear

  1. PEG-somatropin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Growth Hormone Deficiency

    approved mab active

    2 trials

  2. Pegyinterferon-alfa-2a

    Chinese University of Hong Kong

    Chronic Hepaititis B

    approved small molecule completed

    1 trial

  3. Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastroesophageal Reflux Disease

    approved other active

    1 trial

  4. Probiotics

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Kidney Disease

    approved other completed

    1 trial

  5. Propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Urinary Surgery

    approved small molecule completed

    1 trial

  6. Propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nausea and Vomiting

    approved small molecule completed

    1 trial

  7. Proton Pump Inhibitors

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Upper Gastrointestinal Hemorrhage

    approved small molecule active

    1 trial

  8. Qianjin Capsule of Gynaecology

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pelvic Inflammatory Diseases

    approved small molecule active

    1 trial

  9. Qizhitongluo Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ischemic Stroke

    approved small molecule completed

    1 trial

  10. Quick-Acting Heart Reliever

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Stenosis

    approved small molecule completed

    1 trial

  11. Rabbit ATG, (Genzyme)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia

    approved small molecule active

    1 trial

  12. Recombinant human growth hormone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Achondroplasia

    approved small molecule active

    1 trial

  13. Recombinant human growth hormone (r-hGH)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dwarfism, Pituitary

    approved small molecule completed

    1 trial

  14. Recombinant tissue plasminogen activator (rt-PA)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Thromboembolisms

    approved small molecule active

    1 trial

  15. Regimen:TDF+3TC+EFV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hiv

    approved small molecule completed

    1 trial

  16. Regimen：BIC+FTC+TAF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV Infection

    approved small molecule active

    1 trial

  17. Rematazolam Besylate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Emergence Agitation

    approved small molecule active

    1 trial

  18. Reyanning mixture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Tonsillitis

    approved small molecule active

    1 trial

  19. Rosuvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infarction, Anterior Cerebral Artery

    approved small molecule active

    1 trial

  20. Rosuvastatin (5mg，10mg，20mg)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carotid Atherosclerosis

    approved small molecule active

    1 trial

  21. Sabin-IPV and DTaP

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  22. Sabin-IPV+bOPV+bOPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  23. Salmeterol/Fluticasone Propionate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  24. Salvianolate injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Angina

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources